Our results are consistent with Chari et al. (54) and Kim et al. (56) that have been published in the past about the significance of body mass index (BMI), hemoglobin A1c, CA19-9, and carcinoembryonic antigen as predictors of the risk of developing pancreatic cancer. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.